195 related articles for article (PubMed ID: 25771021)
1. Tissue engineering a surrogate niche for metastatic cancer cells.
Seib FP; Berry JE; Shiozawa Y; Taichman RS; Kaplan DL
Biomaterials; 2015 May; 51():313-319. PubMed ID: 25771021
[TBL] [Abstract][Full Text] [Related]
2. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
3. A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone.
Thibaudeau L; Taubenberger AV; Holzapfel BM; Quent VM; Fuehrmann T; Hesami P; Brown TD; Dalton PD; Power CA; Hollier BG; Hutmacher DW
Dis Model Mech; 2014 Feb; 7(2):299-309. PubMed ID: 24713276
[TBL] [Abstract][Full Text] [Related]
4. Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.
González Díaz EC; Sinha S; Avedian RS; Yang F
Acta Biomater; 2019 Nov; 99():18-32. PubMed ID: 31419564
[TBL] [Abstract][Full Text] [Related]
5. Development of a 3D bone marrow adipose tissue model.
Fairfield H; Falank C; Farrell M; Vary C; Boucher JM; Driscoll H; Liaw L; Rosen CJ; Reagan MR
Bone; 2019 Jan; 118():77-88. PubMed ID: 29366838
[TBL] [Abstract][Full Text] [Related]
6. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
[TBL] [Abstract][Full Text] [Related]
7. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.
Meinel L; Karageorgiou V; Hofmann S; Fajardo R; Snyder B; Li C; Zichner L; Langer R; Vunjak-Novakovic G; Kaplan DL
J Biomed Mater Res A; 2004 Oct; 71(1):25-34. PubMed ID: 15316936
[TBL] [Abstract][Full Text] [Related]
8. Tissue-engineered nanoclay-based 3D in vitro breast cancer model for studying breast cancer metastasis to bone.
Kar S; Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2019 Feb; 13(2):119-130. PubMed ID: 30466156
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche.
Templeton ZS; Lie WR; Wang W; Rosenberg-Hasson Y; Alluri RV; Tamaresis JS; Bachmann MH; Lee K; Maloney WJ; Contag CH; King BL
Neoplasia; 2015 Dec; 17(12):849-861. PubMed ID: 26696367
[TBL] [Abstract][Full Text] [Related]
10. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
12. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
[TBL] [Abstract][Full Text] [Related]
13. Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds.
Ye X; Yin X; Yang D; Tan J; Liu G
Tissue Eng Part C Methods; 2012 Jul; 18(7):545-56. PubMed ID: 22250840
[TBL] [Abstract][Full Text] [Related]
14. A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone.
Hesami P; Holzapfel BM; Taubenberger A; Roudier M; Fazli L; Sieh S; Thibaudeau L; Gregory LS; Hutmacher DW; Clements JA
Clin Exp Metastasis; 2014 Apr; 31(4):435-46. PubMed ID: 24510218
[TBL] [Abstract][Full Text] [Related]
15. Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study.
Zhu W; Wang M; Fu Y; Castro NJ; Fu SW; Zhang LG
Acta Biomater; 2015 Mar; 14():164-74. PubMed ID: 25528534
[TBL] [Abstract][Full Text] [Related]
16. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic and adipogenic differentiation of rat bone marrow cells on non-mulberry and mulberry silk gland fibroin 3D scaffolds.
Mandal BB; Kundu SC
Biomaterials; 2009 Oct; 30(28):5019-30. PubMed ID: 19577292
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
[TBL] [Abstract][Full Text] [Related]
19. Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds.
Mauney JR; Nguyen T; Gillen K; Kirker-Head C; Gimble JM; Kaplan DL
Biomaterials; 2007 Dec; 28(35):5280-90. PubMed ID: 17765303
[TBL] [Abstract][Full Text] [Related]
20. Studies of osteotropism on both sides of the breast cancer-bone interaction.
Moreau J; Anderson KM; Mauney JR; Kaplan D; Rosenblatt M
Ann N Y Acad Sci; 2007 Nov; 1117():328-44. PubMed ID: 17584985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
